Wockhardt Limited (BOM:532300)
India · Delayed Price · Currency is INR 2,148.75
-25.35 (-1.17%)
At close: Oct 7, 2026
Wockhardt Market Cap
Wockhardt has a market cap or net worth of 349.52 billion as of October 7, 2026. Its market cap has increased by 50.51% in one year.
Market Cap
349.52B
Enterprise Value
369.12B
Revenue
36.53B
Global Rank
n/a
Country Rank
n/a
PE Ratio
86.47
ChartMarket Cap Chart
Since February 21, 2001, Wockhardt's market cap has increased from 17.40B to 349.52B, an increase of 1,908.32%. That is a compound annual growth rate of 12.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 349.52B | 48.74% |
| Dec 31, 2025 | 235.00B | 2.08% |
| Dec 31, 2024 | 230.20B | 276.45% |
| Dec 29, 2023 | 61.15B | 90.30% |
| Dec 30, 2022 | 32.13B | -29.77% |
| Dec 31, 2021 | 45.75B | -24.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dr. Reddy's Laboratories | 999.66B |
| Lupin | 919.04B |
| Abbott India | 570.16B |
| GlaxoSmithKline Pharmaceuticals | 470.02B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 203.39B |
| Caplin Point Laboratories | 200.09B |
| Jubilant Pharmova | 158.49B |